Recent treatment advances and novel therapeutic approaches in epilepsy

The purpose of this article is to review recent advances in the treatment of epilepsy. It includes five antiepileptic drugs that have been recently added to the pharmacologic armamentarium and surgical techniques that have been developed in the last few years. Finally, we review ongoing research that may have a potential role in future treatments of epilepsy.

• Publication year

  2015

• Venue

  F1000Prime Reports

• Publication date

  2015-05-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.12703/P7-61PMID 26097734PMCID 4447056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of inflammation in epileptogenesis.

  2013influential reference
• Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305

  2013cited by this paper
• Immune mechanisms in epileptogenesis

  2013cited by this paper
• Is mTOR inhibition a systemic treatment for tuberous sclerosis?

  2013influential reference
• Role of hormones and neurosteroids in epileptogenesis

  2013cited by this paper
• Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI).

  2013cited by this paper
• Role of the mTOR signaling pathway in epilepsy.

  2013cited by this paper
• Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.

  2013cited by this paper
• Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

  2012cited by this paper
• Adjunctive perampanel for refractory partial-onset seizures

  2012cited by this paper
• Mechanisms of epileptogenesis and potential treatment targets.

  2011cited by this paper
• Responsive cortical stimulation for the treatment of medically intractable partial epilepsy

  2011cited by this paper
• mTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets

  2011cited by this paper
• Molecular cascades that mediate the influence of inflammation on epilepsy

  2011cited by this paper
• Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

  2011cited by this paper
• Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice

  2011cited by this paper
• The role of inflammation in epilepsy

  2011cited by this paper
• Eslicarbazepine acetate (BIA 2-093)

  2011cited by this paper
• ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.

  2010cited by this paper
• Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research

  2010cited by this paper
• The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.

  2010cited by this paper
• A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.

  2010cited by this paper
• Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy

  2010cited by this paper
• Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial

  2010cited by this paper
• Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

  2010cited by this paper
• Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

  2010cited by this paper
• Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.

  2009cited by this paper
• Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo‐controlled trial

  2009cited by this paper
• Preventing and treating posttraumatic seizures: The human experience

  2009influential reference
• The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy

  2009cited by this paper
• Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

  2009cited by this paper
• The role of the mammalian target of rapamycin (mTOR) in renal disease.

  2009cited by this paper
• Cellular injury and neuroinflammation in children with chronic intractable epilepsy

  2009cited by this paper
• Tumor suppressors and cell metabolism: a recipe for cancer growth.

  2009cited by this paper
• Conserved site for neurosteroid modulation of GABA A receptors.

  2009cited by this paper
• Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition.

  2009influential reference
• Astrocytes in the epileptic brain.

  2008cited by this paper
• Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex

  2008cited by this paper
• Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome

  2008cited by this paper
• Increased expression of caspase 2 in experimental and human temporal lobe epilepsy

  2007influential reference
• Cytokines and neuronal ion channels in health and disease.

  2007cited by this paper
• Lacosamide: a review of preclinical properties.

  2007cited by this paper
• Neurosteroid binding sites on GABA(A) receptors.

  2007cited by this paper
• Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice.

  2007cited by this paper
• Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

  2007cited by this paper
• Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.

  2006cited by this paper
• The Blood–Brain Barrier and Epilepsy

  2006cited by this paper
• Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

  2005cited by this paper
• EFFECT OF NAPROXEN, A NON‐SELECTIVE CYCLO‐OXYGENASE INHIBITOR, ON PENTYLENETETRAZOL‐INDUCED KINDLING IN MICE

  2005cited by this paper
• Growing roles for the mTOR pathway.

  2005cited by this paper
• Anti-epileptogenesis research: the clinical relevance.

  2003cited by this paper
• Tuberous Sclerosis: from Tubers to mTOR

  2003cited by this paper
• Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsion.

  2003cited by this paper
• Epilepsy after brain insult: Targeting epileptogenesis

  2002cited by this paper
• The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.

  2002cited by this paper
• Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy.

  2002cited by this paper
• Interaction of the Novel Anticonvulsant, BIA 2‐093, with Voltage‐Gated Sodium Channels: Comparison with Carbamazepine

  2001cited by this paper
• Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy

  2000influential reference
• Early identification of refractory epilepsy.

  2000cited by this paper
• Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.

  1999cited by this paper
• Autism and Tuberous Sclerosis

  1998cited by this paper
• Recurrent seizures may cause hippocambal damage in temporal lobe epilepsy

  1998cited by this paper
• Commission on European Affairs: Appropriate Standards of Epilepsy Care Across Europe

  1997cited by this paper
• Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.

  1995cited by this paper
• Greenfieldʼs Neuropathology, 5th Edition.

  1993cited by this paper
• Autism and tuberous sclerosis

  1991cited by this paper
• Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes.

  1990cited by this paper
• Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.

  1988cited by this paper
• Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex.

  1987cited by this paper
• Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

  1986cited by this paper
• Modulation of the GABA receptor complex by a steroid anaesthetic.

  1984cited by this paper

• The Concomitant Effect of the Antiepileptic Drug Lacosamide and rTMS on an SH-SY5Y Model of Neuronal Excitability

  2025cites this paper
• Types of Epilepsy Curricula and Their Effectiveness: A Global Scoping Review Protocol of School-Based Educational Interventions

  2025cites this paper
• Potential Anti-epileptic Phytoconstituents: An Updated Review.

  2020cites this paper
• Increase in cognitive function is seen in many single-operated pediatric patients after epilepsy surgery.

  2020cites this paper
• Breakthroughs in neuroactive steroid drug discovery.

  2018cites this paper
• Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies.

  2018cites this paper
• Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs

  2017cites this paper
• Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis

  2016cites this paper
• Targeting Soluble Epoxide Hydrolase for Temporal Lobe Epilepsy

  2016cites this paper
• Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.

  2016cites this paper
• Epilepsy Treatments Quiz

  2015cites this paper